Sources: India's liquefied petroleum gas imports from the US may exceed 1 million tons in June, reaching a record high.

老虎证券2026/06/23 05:03

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Before the outbreak of conflict between Israel, the United States and Iran, and before the disruption of shipping in the Strait of Hormuz, India's monthly import volume of liquefied petroleum gas (LPG) was about 2 million tons, with 90% imported from Middle Eastern oil-producing countries. Official data show that LPG is the main cooking fuel for Indian households. A blockade of the Strait led to imports plunging to a low of 696,000 tons in April; the import volume rebounded to 1.15 million tons in May. Prior to this supply crisis, India was planning to increase its purchases of US LPG to around 10% of its total imports, aiming to adjust the trade structure with the US and balance the bilateral trade deficit.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

October 6 - Genmab (GMAB.CO) shares rose about 8%, reaching a three-year high and leading the STOXX 600 index (.STOXX). Genmab and AbbVie ABBV.N announced on Monday (link) that their combination therapy for blood cancer reduced the risk of disease progression and death in a late-stage clinical trial. The two companies stated that, compared to R-CHOP regimen alone, the combination therapy reduced the risk of disease progression or death in newly diagnosed patients by 51%. Analysts at Jefferies described this result as "impressive". The brokerage added that the data "easily met the bar for success" and exceeded investor expectations of approximately 40%. TD Cowen stated that the data establishes the combination therapy as a potential new standard of care, with peak market potential expected to exceed $3 billion. (For convenience of non-English speakers, Reuters has automated this report into several other languages. Automated translations may contain errors or lack necessary context, and Reuters makes no guarantees as to their accuracy. The automated translation is provided for reader convenience, and Reuters bears no responsibility for any damages or losses resulting from use of the automated translation.)

路透社•2026/10/06 07:26